Panel Discussion: How has the Recent Approval of Disease Modifying Drugs Impacted the Treatment Landscape for Alzheimer’s Disease?
Time: 9:30 am
day: Conference Day Two
Details:
- Exploring the potential impact on novel target discovery and development strategies
- Illuminating the impact on clinical development plans in demonstrating meaningful effect on patients
- Reviewing how trial design might be impacted with Leqembi as a comparator or combination partner in future studies
